The role of interaction between keratinocytes and type 2 inflammation in the pathogenesis of atopic dermatitis
Patients with atopic dermatitis (AD) have skin barrier dysfunction, which is closely related to keratinocyte (KC) abnormalities. Upon stimulation by external factors, KCs release a large number of inflammatory mediators, thereby activating type 2 inflammation, which, in turn, exacerbates skin barrie...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Книга |
| Опубліковано: |
editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology,
2024-01-01T00:00:00Z.
|
| Предмети: | |
| Онлайн доступ: | Connect to this object online. |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_ffc5d2dbbb0f424c8c5b80bc2d32833c | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Ruiwen ZHANG |e author |
| 700 | 1 | 0 | |a Xiaobao HUANG |e author |
| 700 | 1 | 0 | |a Fang WANG |e author |
| 245 | 0 | 0 | |a The role of interaction between keratinocytes and type 2 inflammation in the pathogenesis of atopic dermatitis |
| 260 | |b editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology, |c 2024-01-01T00:00:00Z. | ||
| 500 | |a 1674-8468 | ||
| 500 | |a 10.3969/j.issn.1674-8468.2024.01.009 | ||
| 520 | |a Patients with atopic dermatitis (AD) have skin barrier dysfunction, which is closely related to keratinocyte (KC) abnormalities. Upon stimulation by external factors, KCs release a large number of inflammatory mediators, thereby activating type 2 inflammation, which, in turn, exacerbates skin barrier dysfunction. Thus, the interaction between KCs and type 2 inflammation is a key factor in the pathogenesis of AD, and exacerbation of inflammation and pruritus. At present, the innovative medications, such as biologics and small molecule drugs, have been shown anti-inflammatory effects in AD. Studies also demonstrate their role in skin barrier repair. Therefore, research on the interaction between KCs and type 2 inflammation will help understand the pathogenesis of AD and provide evidence to optimize treatment strategies for AD. | ||
| 546 | |a ZH | ||
| 690 | |a atopic dermatitis | ||
| 690 | |a keratinocyte | ||
| 690 | |a type 2 inflammation | ||
| 690 | |a biologics | ||
| 690 | |a small molecule drugs | ||
| 690 | |a Dermatology | ||
| 690 | |a RL1-803 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Pifu-xingbing zhenliaoxue zazhi, Vol 31, Iss 1, Pp 48-55 (2024) | |
| 787 | 0 | |n http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2024.01.009 | |
| 787 | 0 | |n https://doaj.org/toc/1674-8468 | |
| 856 | 4 | 1 | |u https://doaj.org/article/ffc5d2dbbb0f424c8c5b80bc2d32833c |z Connect to this object online. |